Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Connie H Miller

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Thrombosis Research|October 4, 2015
Improving the performance of factor VIII inhibitor tests in hemophilia AConnie H Miller
Blood|August 15, 2015
Game, set, match for factor VIII mismatch?Connie H Miller
Clinical Obstetrics and Gynecology|November 4, 2006
Laboratory tests for the diagnosis of thrombotic disordersConnie H Miller
The Application of Clinical Genetics|December 1, 2021
The Clinical Genetics of Hemophilia B (Factor IX Deficiency)Connie H Miller
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 5, 2021
Monitoring of von Willebrand factor inhibitors in patients with type 3 von Willebrand disease using a quantitative assayConnie H Miller
Journal of Thrombosis and Haemostasis : JTH|June 27, 2021
The chromogenic Bethesda assay and the Nijmegen-Bethesda assay for factor VIII inhibitors in hemophilia A patients: Are they equivalent?Connie H Miller, Brian Boylan
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 14, 2020
Genetic causes of haemophilia in women and girlsConnie H Miller, Christopher J Bean
American Journal of Hematology|January 24, 2015
Impact of inhibitors on hemophilia A mortality in the United StatesChristopher E Walsh, J Michael Soucie, Connie H Miller, et al.
American Journal of Preventive Medicine|March 25, 2010
Complications associated with carrier status among people with blood disorders: a commentaryW Craig Hooper, Connie H Miller, Nigel S Key
Thrombosis and Haemostasis|August 3, 2002
Evaluation of two automated methods for measurement of the ristocetin cofactor activity of von Willebrand factorConnie H Miller, S Jean Platt, Christine Daniele, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Thrombosis Research|October 4, 2015
Improving the performance of factor VIII inhibitor tests in hemophilia AConnie H Miller
Blood|August 15, 2015
Game, set, match for factor VIII mismatch?Connie H Miller
Clinical Obstetrics and Gynecology|November 4, 2006
Laboratory tests for the diagnosis of thrombotic disordersConnie H Miller
The Application of Clinical Genetics|December 1, 2021
The Clinical Genetics of Hemophilia B (Factor IX Deficiency)Connie H Miller
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 5, 2021
Monitoring of von Willebrand factor inhibitors in patients with type 3 von Willebrand disease using a quantitative assayConnie H Miller
Journal of Thrombosis and Haemostasis : JTH|June 27, 2021
The chromogenic Bethesda assay and the Nijmegen-Bethesda assay for factor VIII inhibitors in hemophilia A patients: Are they equivalent?Connie H Miller, Brian Boylan
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 14, 2020
Genetic causes of haemophilia in women and girlsConnie H Miller, Christopher J Bean
American Journal of Hematology|January 24, 2015
Impact of inhibitors on hemophilia A mortality in the United StatesChristopher E Walsh, J Michael Soucie, Connie H Miller, et al.
American Journal of Preventive Medicine|March 25, 2010
Complications associated with carrier status among people with blood disorders: a commentaryW Craig Hooper, Connie H Miller, Nigel S Key
Thrombosis and Haemostasis|August 3, 2002
Evaluation of two automated methods for measurement of the ristocetin cofactor activity of von Willebrand factorConnie H Miller, S Jean Platt, Christine Daniele, et al.
Pageof 4